1111637-91-2

Basic information

• Product Name: 3-Methyl-5-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-ylaMine
• Synonyms: 3-Methyl-5-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-ylaMine
• CAS NO: 1111637-91-2
• Molecular Formula: C12H19BN2O2
• Molecular Weight: 234.10246
• Mol File: 1111637-91-2.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Methyl-5-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-ylaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Methyl-5-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-ylaMine(1111637-91-2)
• EPA Substance Registry System: 3-Methyl-5-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-ylaMine(1111637-91-2)

Safety Data

• Hazardous Substances Data: 1111637-91-2(Hazardous Substances Data)

Usage

General Description

3-Methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-ylamine is a chemical compound with a molecular formula C14H22BNO2. It is a pyridine derivative containing a boron atom linked to a dioxaborolane group. 3-Methyl-5-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-ylaMine is typically used as a building block in organic synthesis and pharmaceutical research. It is known for its potential applications in the development of novel drugs and as a reagent in the synthesis of complex organic molecules. It is also used as a ligand in coordination chemistry and in the development of new materials. Additionally, this chemical compound may have potential uses in the field of agricultural chemicals and as an intermediate in the production of specialty chemicals.

Upstream product

• 3430-21-5 5-bromo-3-methyl-pyridin-2-ylamine 
• 73183-34-3 bis(pinacol)diborane 

Relevant articles and documents

Small molecule compound

The invention provides a small molecular compound, The small molecular compound is characterized by having a structure as shown in the following molecular general formula, wherein X1 and X2 are selected from carbon or nitrogen, G1 is a carbon ring or a heterocyclic ring with aromaticity, any one or more hydrogen atoms on the G1 ring are substituted by R1, wherein R1 is selected from nitrogen-containing groups. The small molecule compound can be used as an efficient and specific JAK kinase inhibitor, especially a Tyk2 inhibitor, and/or a JAK1 inhibitor, and/or a JAK1/Tyk2 dual inhibitor, or a Tyk2/JAK1 dual inhibitor or a Tyk2/Jak2 dual inhibitor.

PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE

Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.